Based on SEC filing data. A pre-seed stage pharmaceutical corporation based in Las Vegas, Nevada has raised $389,763 in equity funding. The company is in early development within the pharma sector.
Get notified the moment EnzymeBioSystems files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.